CSIMarket
 


National Research Corporation  (NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

NRC's Net Income Growth by Quarter and Year

National Research's Net Income results by quarter and year




NRC Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 9.63 8.21 8.70
III Quarter September 8.30 9.66 9.58 8.12
II Quarter June 8.32 8.94 7.72 7.39
I Quarter March 8.54 9.23 11.76 8.20
FY   25.16 37.46 37.27 32.41



NRC Net Income third quarter 2022 Y/Y Growth Comment
National Research Corporation reported fall in Net Income in the third quarter 2022 by -14.1% to $ 8.30 millions, from the same quarter in 2021.
The decline in the third quarter 2022 National Research Corporation's Net Income compares unfavorably to the Company's average Net Income growth of 0.83%.

Looking into third quarter 2022 results within Medical Laboratories industry 8 other companies have achieved higher Net Income growth. While National Research Corporation' s Net Income decrease of -14.1% ranks overall at the positon no. 1527 in the third quarter 2022.




NRC Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 17.3 % -5.63 % 11.54 %
III Quarter September -14.1 % 0.84 % 17.98 % 16.17 %
II Quarter June -6.94 % 15.8 % 4.47 % -7.04 %
I Quarter March -7.48 % -21.51 % 43.41 % 12.18 %
FY   - 0.51 % 15 % 7.85 %

Financial Statements
National Research's third quarter 2022 Net Income $ 8.30 millions NRC's Income Statement
National Research's third quarter 2021 Net Income $ 9.66 millions Quarterly NRC's Income Statement
New: More NRC's historic Net Income Growth >>


NRC Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -0.31 % -14.3 % 7.14 %
III Quarter September -0.26 % 8.05 % 24.09 % 9.88 %
II Quarter June -2.58 % -3.14 % -34.35 % -9.88 %
I Quarter March -11.32 % 12.42 % 35.17 % 5.13 %
FY (Year on Year)   - 0.51 % 15 % 7.85 %




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #106
Overall #1527

Net Income Y/Y Growth Statistics
High Average Low
11.35 % 0.83 % -10.87 %
(Sep. 30, 2013)   (March 31, 2015)
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #106
Overall #1527
Net Income Y/Y Growth Statistics
High Average Low
11.35 % 0.83 % -10.87 %
(Sep. 30, 2013)   (March 31, 2015)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

National Research's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
56.92 % 2.07 % -34.37 %
(Dec 31 2017)  


NRC's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 National Research Corporation realized decrease in Net Income from the previous quarter by -0.26% to $ 8.30 millions, from $ 8.32 millions achived in the previous quarter.

Albeit cyclical influence normally energize III. Quarter 2022 performance, that plainly could not be enough to recover Medical Laboratories's company performance, Ava  Hall, market advisor wrote and wrote that average quarter on quarter Net Income growth is at 2.07% for the Medical Laboratories's company.

Within Medical Laboratories industry 4 other companies have achieved higher Net Income quarter on quarter growth. While National Research's Net Income growth quarter on quarter, overall rank is 1172.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #74
Overall #1172
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #74
Overall #1172
Net Income Q/Q Growth Statistics
High Average Low
56.92 % 2.07 % -34.37 %
(Dec 31 2017)  


NRC's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 National Research Corporation realized decrease in Net Income from the previous quarter by -0.26% to $ 8.30 millions, from $ 8.32 millions declared in the previous reporting period.

Some periodic influence were not able to salvage the III. Quarter for the National Research Corporation, Ava  Hall, market advisor wrote, she cited little pessimism for the National Research's perspective, she identified further challenges onward for the Medical Laboratories's company and mentioned that average quarter on quarter Net Income growth is at 2.07% for the Medical Laboratories's company.

Within Medical Laboratories industry 4 other companies have achieved higher Net Income quarter on quarter growth. While National Research's Net Income growth quarter on quarter, overall rank is 1172.


National Research's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ 34.79 $ 36.15 $ 36.77 $ 37.47 $ 36.05
Y / Y Net Income Growth (TTM) -3.48 % 0.51 % 5.86 % 0.55 % -4.51 %
Year on Year Net Income Growth Overall Ranking # 1092 # 957 # 877 # 1059 # 1157
Seqeuential Net Income Change (TTM) -3.76 % -1.69 % -1.85 % 3.94 % 0.22 %
Seq. Net Income Growth (TTM) Overall Ranking # 1527 # 1050 # 985 # 835 # 1216




Cumulative Net Income growth Comment
For the 12 months ended Sep 30 2022 National Research reported a decrease in Net Income by -3.48% year on year, to $35 millions, compare to the 0.51% growth at Jun 30 2022.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 957 to 1092.

Net Income TTM Q/Q Growth Statistics
High Average Low
11.35 %
0.83 %
-10.87 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 73
Overall # 1092

Net Income TTM Y/Y Growth Statistics
High Average Low
137.12 %
15.47 %
-5.2 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 106
S&P 500 # 1527
Cumulative Net Income growth Comment
For the 12 months ended Sep 30 2022 National Research reported a decrease in Net Income by -3.48% year on year, to $35 millions, compare to the 0.51% growth at Jun 30 2022.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 957 to 1092.

Net Income TTM Q/Q Growth Statistics
High Average Low
11.35 %
0.83 %
-10.87 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 73
Overall # 1092

Net Income TTM Y/Y Growth Statistics
High Average Low
137.12 %
15.47 %
-5.2 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 106
S&P 500 # 1527




Other Net Income Growth
Medical Laboratories Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NRC's Net Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NRC's Competitors
Net Income Growth for National Research's Suppliers
Net Income Growth for NRC's Customers

You may also want to know
NRC's Annual Growth Rates NRC's Profitability Ratios NRC's Asset Turnover Ratio NRC's Dividend Growth
NRC's Roe NRC's Valuation Ratios NRC's Financial Strength Ratios NRC's Dividend Payout Ratio
NRC's Roa NRC's Inventory Turnover Ratio NRC's Growth Rates NRC's Dividend Comparisons



Companies with similar Net Income decrease for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Pediatrix Medical Group Inc -0.19%$ -0.195 millions
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc -4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Te Connectivity ltd -10.83%$ -10.831 millions
Semler Scientific inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Lemaitre Vascular Inc-16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Molecular Templates Inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Khosla Ventures Acquisition Co -22.51%$ -22.507 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Reynolds Consumer Products Inc -27.27%$ -27.273 millions
Taitron Components Incorporated-28.61%$ -28.614 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WLL's Profile

Stock Price

WLL's Financials

Business Description

Fundamentals

Charts & Quotes

WLL's News

Suppliers

WLL's Competitors

Customers & Markets

Economic Indicators

WLL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071